Vaccinia virus as a vector
Beaud, G.; Mars, M.; Vassef, A.
Developments in Biological Standardization 66: 49-54
1987
ISSN/ISBN: 0301-5149 PMID: 3582771 Document Number: 303682
Document emailed within 1 workday
Related Documents
Wojcik, J. 1995: Expression of feline immunodeficiency virus (FIV) gag gene in vaccinia virus vector Acta Microbiologica Polonica 44(2): 191-196Chunduru, S.K.; Sutherland, R.M.; Stewart, G.A.; Doms, R.W.; Paterson, Y. 1996: Exploitation of the Vbeta8.2 T cell receptor in protection against experimental autoimmune encephalomyelitis using a live vaccinia virus vector Journal of Immunology 156(12): 4940-4945
Marcelino, J.é M.; Borrego, P.; Rocha, C.; Barroso, H.; Quintas, A.; Novo, C.; Taveira, N. 2010: Potent and broadly reactive HIV-2 neutralizing antibodies elicited by a vaccinia virus vector prime-C2V3C3 polypeptide boost immunization strategy Journal of Virology 84(23): 12429-12436
Topa, P.K.; Rao, K.V. 1976: Extraction of vaccinia virus and purification of vaccinia elementary body suspension with Mafron 11 Indian Journal of Medical Research 64(10): 1421-1431
Sitnikov, B.S.; Gendon, I.Z. 1970: "Rescue" of the rct40 plus-marker of vaccinia virus in different methods of inactivation of the donor virus Voprosy Virusologii 15(3): 278-283
Haishi, S.; Imai, H.; Hirai, K.; Igarashi, A.; Kato, S. 1989: Expression of envelope glycoprotein (E) of Japanese encephalitis virus by recombinant vaccinia virus Acta Virologica 33(6): 497-503
Sottnek, H.M.; Cassel, W.A.; Campbell, W.G. 1975: The pathogenesis of Vaccinia virus toxicity. I. the role of virus-platelet interaction Laboratory Investigation; a Journal of Technical Methods and Pathology 33(5): 514-521
Sviatchenko, V.A.; Agapov, E.V.; Urmanov, I.Kh.; Serpinskiĭ, O.I.; Frolov, I.V.; Kolykhalov, A.A.; Ryzhikov, A.B.; Netesov, S.V. 1993: The immunogenic properties of a recombinant vaccinia virus with an incorporated DNA copy of the 26S RNA of the Venezuelan equine encephalomyelitis virus Voprosy Virusologii 38(5): 222-226
Bruckner, S.; Ciugarin, M.; Cotarcea, S.; Istodor, N. 1972: Double infection with vaccinia virus and echo virus Annales de Pediatrie 19(3): 253-255
Cherney, T.M.; Schultz, R.D. 1996: Viral status and antibody response in cattle inoculated with recombinant bovine leukemia virus-vaccinia virus vaccines after challenge exposure with bovine leukemia virus-infected lymphocytes American Journal of Veterinary Research 57(6): 812-818
Zarling, J.M.; Eichberg, J.W.; Moran, P.A.; McClure, J.; Sridhar, P.; Hu, S.L. 1987: Proliferative and cytotoxic T cells to AIDS virus glycoproteins in chimpanzees immunized with a recombinant vaccinia virus expressing AIDS virus envelope glycoproteins Journal of Immunology 139(4): 988-990
Smithwick, E.M.; Steiner, M.; Quick, J.D. 1972: Vaccinia virus and tuberculin reactivity Pediatrics 50(4): 660-661
Ghendon, Y.Z.; Rozina, E.E.; Marchenko, A.T. 1973: On the "neuropathogenicity" mechanism of vaccinia virus Acta Virologica 17(2): 169
Meshcheriakova, I.A.; El'darov, M.A.; Beales, L.; Skriabin, K.G.; Lomonossoff, G.P. 2008: Production of hepatitis B virus core particles protein in plants, by using cowpea mosaic virus-based vector Voprosy Virusologii 53(3): 15-20
Mückter, H.; Sous, H.; Poszich, G.; Nijssen, J. 1971: Rifampicin inhibition of vaccinia virus in mice Arzneimittel-Forschung 21(10): 1571-1572
Korbecki, M.; Bankowski, A.; Filczak, K.; Klimek, A. 1985: Dipyridamole as an inhibitor of vaccinia virus replication Molekuliarnaia Genetika Mikrobiologiia i Virusologiia 1: 29-32
Kochneva, G.V.; Babkina, I.N.; Lupan, T.A.; Grazhdantseva, A.A.; Iudin, P.V.; Sivolobova, G.F.; Shvalov, A.N.; Popov, E.G.; Babkin, I.V.; Netesov, S.V.; Chumakov, P.M. 2013: Apoptin enhances the oncolytic activity of vaccinia virus Molekuliarnaia Biologiia 47(5): 842-852
Chen, H.; Padmanabhan, R. 1994: A modified method for isolation of recombinant vaccinia virus Biotechniques 17(1): 40; 42
Cremer, K.; Wohlenberg, C.; Notkins, A.L.; Mackett, M.; Moss, B. 1985: Vaccinia virus recombinant that expresses the herpes simplex virus type 1 glycoprotein d gene protects mice against lethal challenge by herpes simplex virus type 1 or herpes simplex type 2 and the establishment of a latent ganglionic infection by herpes simplex virus type 1 Lerner, R A , R M Chanock And F Brown (Ed ) Vaccines 85: Molecular And Chemical Basis Of Resistance to Parasitic, Bacterial, And Viral Diseases; Meeting, 1983 Xxi+407p Cold Spring Harbor Laboratory: Cold Spring Harbor, N Y , Usa Illus Paper 169-174
Cremer, K.; Wohlenberg, C.; Notkins, A.L.; Mackett, M.; Moss, B. 1985: Vaccinia virus recombinant that expresses the herpes simplex virus type 1 glycoprotein d gene protects mice against lethal challenge by herpes simplex virus type 1 or herpes simplex type 2 and the establishment of a latent ganglionic infection by herpes simplex virus type 1 Lerner, R A , R M Chanock And F Brown (Ed ) Vaccines 85: Molecular And Chemical Basis Of Resistance to Parasitic, Bacterial, And Viral Diseases; Meeting, 1983 Xxi+407p Cold Spring Harbor Laboratory: Cold Spring Harbor, N Y , Usa Illus Paper 169-174